Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential (Q34557101)

3 August 2017

1 reference

title

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential (English)

1 reference

3 August 2017

1 reference

Carmelo Scarpignato

1

1 reference

3 August 2017

Iva Pelosini

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2005

1 reference

3 August 2017

1 reference

3 August 2017

volume

51 Suppl 1

1 reference

3 August 2017

page(s)

36-66

1 reference

Antibiotics and anaerobes of gut origin

3 August 2017

cites work

1 reference

Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity

21 January 2018

1 reference

Pathophysiology and impact of enteric bacterial and protozoal infections: new approaches to therapy

21 January 2018

1 reference

Gastrointestinal infections

21 January 2018

1 reference

The role of the gut flora in health and disease, and its modification as therapy

21 January 2018

1 reference

Gut flora in health and disease

21 January 2018

1 reference

Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?

21 January 2018

1 reference

21 January 2018

Vancomycin: an update

1 reference

21 January 2018

1 reference

Pseudomembranous colitis: causes and cures

21 January 2018

1 reference

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

Chemistry and biology of the ramoplanin family of peptide antibiotics

21 January 2018

1 reference

Deafness Complicating Antibiotic Therapy of Hepatic Encephalopathy

21 January 2018

1 reference

Recent trends in rifamycin research

21 January 2018

1 reference

In vitro activity and fecal concentration of rifaximin after oral administration

21 January 2018

1 reference

Rifaximin: in vitro and in vivo antibacterial activity--a review

21 January 2018

1 reference

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

21 January 2018

1 reference

In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species

21 January 2018

1 reference

In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions

21 January 2018

1 reference

In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania.

21 January 2018

1 reference

Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas

21 January 2018

1 reference

Antibiotic resistance from two perspectives: man and microbe

21 January 2018

1 reference

A review of the role of antibiotic policies in the control of antibiotic resistance

21 January 2018

1 reference

Aminoglycoside antibiotic resistance by enzymatic deactivation

21 January 2018

1 reference

Antibacterial susceptibility testing in the clinical laboratory

21 January 2018

1 reference

Antibiotic susceptibility and resistance testing: an overview

21 January 2018

1 reference

Rifaximin in the treatment of infectious diarrhea

21 January 2018

1 reference

Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats

21 January 2018

1 reference

Management of hepatic encephalopathy: role of rifaximin

21 January 2018

1 reference

Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin

21 January 2018

1 reference

Management of diverticular disease: is there room for rifaximin?

21 January 2018

1 reference

Management of inflammatory bowel disease: does rifaximin offer any promise?

21 January 2018

1 reference

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

21 January 2018

1 reference

The use of rifampicin in staphylococcal infections--a review

21 January 2018

1 reference

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci

21 January 2018

1 reference

A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports

21 January 2018

1 reference

Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin

21 January 2018

1 reference

Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis

21 January 2018

1 reference

Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration

21 January 2018

1 reference

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

21 January 2018

1 reference

Drug interactions between oral contraceptives and antibiotics

21 January 2018

1 reference

The pathogenesis of gastrointestinal bacterial overgrowth

21 January 2018

1 reference

Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy

21 January 2018

1 reference

Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract

21 January 2018

1 reference

In vitro activity of rifaximin, a topical rifamycin derivative, against Chlamydia trachomatis

21 January 2018

1 reference

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics

21 January 2018

1 reference

Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility

21 January 2018

1 reference

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly

21 January 2018

1 reference

Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

21 January 2018

1 reference

Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome

21 January 2018

1 reference

Clostridium difficile infection: responses, relapses and re-infections

21 January 2018

1 reference

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

21 January 2018

1 reference

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

New perspectives in antibiotic prophylaxis for intra-abdominal surgery

21 January 2018

1 reference

Surgical site infections: epidemiology and prevention

21 January 2018

1 reference

Short-term prophylaxis in clean-contaminated surgery

21 January 2018

1 reference

Mechanical and antibacterial bowel preparation in colon and rectal surgery

21 January 2018

1 reference

Is single-dose antibiotic prophylaxis sufficient for any surgical procedure?

21 January 2018

1 reference

21 January 2018

Antibiotic side effects

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

21 January 2018

1 reference

Treatment of Helicobacter pylori infection. Indications and regimens: an update

21 January 2018

1 reference

Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects

21 January 2018

1 reference

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

Towards the ideal regimen for Helicobacter pylori eradication: the search continues

21 January 2018

1 reference

Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy

21 January 2018

1 reference

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

Review article: the treatment of refractory Helicobacter pylori infection

21 January 2018

1 reference

Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts

21 January 2018

1 reference

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

21 January 2018

1 reference

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives

21 January 2018

1 reference

Bacterial infection of pancreatic necrosis: role of bacterial translocation, impact of antibiotic treatment

21 January 2018

1 reference

Bacterial translocation and its prevention in acute pancreatitis

21 January 2018

1 reference

IAP Guidelines for the Surgical Management of Acute Pancreatitis

21 January 2018

1 reference

Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial

21 January 2018

1 reference

Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis

21 January 2018

1 reference

Gastrointestinal dysmotility in patients with acute pancreatitis

21 January 2018

1 reference

Review article: spontaneous bacterial peritonitis--diagnosis, treatment and prevention

21 January 2018

1 reference

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

21 January 2018

1 reference

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

21 January 2018

1 reference

Gut microflora in the pathogenesis of the complications of cirrhosis

21 January 2018

1 reference

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

21 January 2018

1 reference

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

21 January 2018

1 reference

The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial

21 January 2018

1 reference

Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?

21 January 2018

1 reference

Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?

21 January 2018

1 reference

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

21 January 2018

1 reference

Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: diagnosis by wireless capsule endoscopy

21 January 2018

1 reference

Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug

21 January 2018

1 reference

Resistance of germfree rats to indomethacin-induced intestinal lesions

21 January 2018

1 reference

Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism

21 January 2018

1 reference

Dysbiosis in inflammatory bowel disease

21 January 2018

1 reference

The role of antibiotics in the management of Crohn's disease

21 January 2018

1 reference

Is metronidazole carcinogenic?

21 January 2018

1 reference

Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales

21 January 2018

1 reference

The Ames Salmonella/microsome mutagenicity assay

21 January 2018

1 reference

Induction of gene conversion in diploid yeast by chemicals: Correlation with mutagenic action and its relevance in genotoxicity screening

21 January 2018

1 reference

Drug excretion into breast milk--overview

21 January 2018

1 reference

A teratological study of aminoglycoside antibiotic treatment during pregnancy

21 January 2018

1 reference

Solution structure of rifaximin and its synthetic derivative rifaximin OR determined by experimental NMR and theoretical simulation methods.

21 January 2018

1 reference

Evolving therapy for Helicobacter pylori infection

21 January 2018

1 reference

Bacterial translocation of enteric organisms in patients with cirrhosis

21 January 2018

1 reference

Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1136/GUT.31.12.1358

Identifiers

DOI

10.1159/000081990

1 reference

3 August 2017

1 reference